EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Central serous chorioretinopathy imaging biomarkers as potential indicators of response to subthreshold nanosecond laser

Vesna Bosic, Doris Fraenkel, Hajra Mudassar, Hakan Kaymak, Berthold Seitz, Alaa Din Abdin

Indian Journal of Ophthalmology · 2025

DOI: 10.4103/ijo.ijo_450_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2025. Verfasst von Vesna Bosic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Saarland University Medical Center, Homburg, Germany. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Tomography, Optical Coherence, Fluorescein Angiography, Laser Coagulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The aim of the study was to evaluate optical coherence tomography (OCT) and indocyanine green angiography (ICGA) biomarkers in patients with chronic central serous chorioretinopathy (cCSC) as potential indicators of response to treatment with subthreshold nanosecond laser (NSL).

Methods

In this retrospective study, we examined 36 eyes of 32 cCSC patients after NSL. High response (HR) was defined as complete resolution of subretinal fluid (SRF) 3 months after first NSL treatment, full response (FR) as complete resolution of SRF, 3 months after the last NSL, with all NSL sessions occurring within 1 year from the first NSL. Biomarkers included central macular thickness (CMT), subfoveal choroidal thickness (SFCT), and intervortex venous anastomosis (IVA).

Results

Patients were 54 ± 12 years old on average; 86% were male. OCT at baseline showed a mean CMT of 364 ± 130 µm and SFCT of 292 ± 45 µm; 64% showed IVA in ICGA. HR was seen in 50% and FR in 78%. Higher IVA rates (83% vs. 44%, P = 0.03) predicted poor response after the first NSL. Patients with IVA presence at baseline showed a statistically significant higher likelihood of requiring more than one NSL session compared to those without IVA presence (57% vs. 15%, P = 0.02).

Conclusion

OCT and ICGA biomarkers may play a role as indicators of anatomical responses to NSL. Patients with IVA at baseline showed a poor first response and may need repetitive laser treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyTomography, Optical CoherenceFluorescein AngiographyLaser CoagulationChoroidVisual AcuityHumansMaleRetrospective StudiesMiddle AgedFemaleBiomarkersFundus OculiFollow-Up StudiesAdultIndocyanine GreenAgedColoring Agents

Stichwörter der Autor:innen

Biomarkercentral serous chorioretinopathyindocyanine green angiographyintervortex vein anastomosisoptical coherence tomographypachychoroid disease spectrumsubtreshold nanosecond laser

Substanzen

BiomarkersIndocyanine GreenColoring Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, Saarland University Medical Center, Homburg, Germany.
  • Internationale Innovative Ophthalmochirurgie GbR (I.I.O.), Düsseldorf, Germany.

Zitieren

APA

Bosic, V., Fraenkel, D., Mudassar, H., Kaymak, H., Seitz, B., & Abdin, A. D. (2025). Central serous chorioretinopathy imaging biomarkers as potential indicators of response to subthreshold nanosecond laser. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_450_25

Vancouver

Bosic V, Fraenkel D, Mudassar H, Kaymak H, Seitz B, Abdin AD. Central serous chorioretinopathy imaging biomarkers as potential indicators of response to subthreshold nanosecond laser. Indian Journal of Ophthalmology. 2025. doi:10.4103/ijo.ijo_450_25

BibTeX
@article{Bosic2025,
  author = {Bosic, Vesna and Fraenkel, Doris and Mudassar, Hajra and Kaymak, Hakan and Seitz, Berthold and Abdin, Alaa Din},
  title = {Central serous chorioretinopathy imaging biomarkers as potential indicators of response to subthreshold nanosecond laser},
  journal = {Indian Journal of Ophthalmology},
  year = {2025},
  doi = {10.4103/ijo.ijo_450_25}
}
Kostenlos starten →